Sign in
PHIO Stock Price, Chart, Stats & News
Phio Pharmaceuticals Corp.
Save
11.97M
Market cap
–
Current P/E
0.31x
Forward P/E
PHIO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -40.48% |
ROE | -66.59% |
D/E | – |
Interest coverage ratio | – |
PHIO valuation
P/E | – |
P/S | – |
P/B | 0.73x |
P/CF | -1.83x |
P/FCF | -1.83x |
P/OCF | -1.83x |
PEG | -4065.79x |
EV multiple | -3.96x |
About
Phio Pharmaceuticals Corp. is a U. S.-based company dedicated to creating immune-system-focused cancer treatments. Their proprietary INTASYL therapeutic platform aims to influence both tumor and immune cells through the precise regulation of immune system genes.
Similar securities
Based on sector and market capitalization
Report issue